Quick-Med Technologies, a life sciences company, has entered into a joint development agreement with Foster, a member of PolyMedex Discovery Group, to collaborate in applying Quick-Med's Nimbus technology to thermoplastics for catheters and other medical product applications.
Subscribe to our email newsletter
According to Quick-Med, the Nimbus is a next-generation wound care technology that is non-toxic, long-lasting and not blocked by organics such as blood, urine and perspiration.
Ladd Greeno, CEO of Quick-Med, said: “We are excited to team with Foster to incorporate our Nimbus technology in catheters. Foster is a respected leader developing advanced biomedical materials to meet the requirements of medical device manufacturers. This collaboration will leverage Nimbus technology to a next generation of antimicrobial catheters to address growing infection concerns.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.